Hemidesmus

Other Names

AnantaAnantamulAnantamulaAnantamulahAnantmoolAnantmulAnantoolaAnantvelAsphotaBalyamCanadanaCountry sarsaparillaDhavalasarivaFalse sarsaparillaGopaGopabandhuGopakanyaGopangiGopavalliGopiHemidesmus indicus (L.) R.Br. ex Schult.HindisalsaIndian sarsaparillaKapuriKaralaKrishodariLataMadhuriMagrabuMuttavapylagamuNagajihvaNamdaberuNannaariNannariNannari sharbatNarunariNaruneendiNarunentiNarunintiOnotomuloPeriploca indica L.PratanikaSalsaSaradiSarivaSarsapillaShgandhiShveta SarivaShyamaSogadaberuSogade BeruSphotaSugandhaSugandhiSugandhimulaSugandhipalaSuguddimaloSungandhipalaUpalasriUpalsanUpalsariUparsalUshbaUtpala Sariva

Synopsis

Hemidesmus indicus (Indian Sarsaparilla): A Comprehensive Reference

1. Identity, Botanical Description, and Natural Source

Hemidesmus indicus (L.) R. Br. belongs to the family Asclepiadaceae (now subsumed into the expanded family Apocynaceae under APG III molecular systematics) and is commonly called Indian sarsaparilla, anantamool, or nannari. Historically classified in Asclepiadaceae, the species was transferred to the broader Apocynaceae following the Angiosperm Phylogeny Group III (APG III) system in 2009, based on molecular and morphological evidence integrating the former families Asclepiadaceae and Periplocaceae. The genus Hemidesmus comprises twining shrubs native primarily to South and Southeast Asia, with H. indicus as its sole widely recognized species.

It is a slender, laticiferous, twining, perennial, fast-growing prostrate or semi-erect wiry shrub with sparse, long, rigid, tuberous, woody and aromatic root system. It is a perennial shrub with a woody rootstock and many thin, wiry laticiferous branches with purple-brown bark, diffusely twining or prostrate and half erect. This plant is native to India and may be found growing in habitats ranging from mesophytic to semi-dry in the lowlands and up to 600 m in height. It especially grows in open scrub jungles, hedges, and uncultivated land.

Synonyms and common names: The plant carries many vernacular names across India, including Sariva, Sarsapilla, Nannari, Naruneendi, Narunari, Anantoola, Karala, Krishodari, Hindisalsa, Upalsan, Suguddimalo, Sugandhipala, Ushba, Anantvel, and Onotomulo. In different linguistic traditions it is known as Anantamul in Hindi, Ushba Hindi in Urdu, Ushbahindi in Persian, and Sariva in Sanskrit. In Sanskrit, the name Anantamul or Sariva means "eternal root" — a symbol of longevity and purification.

Geographical distribution: The plant is native to India, primarily in South Asian countries such as India, Pakistan, Sri Lanka, Bangladesh, Maldives, Iran, and the Moluccas. It has been found mostly throughout India from the Indo-Gangetic plains, eastern parts up to Assam, and across Southern India in mesophytic and semidry environments. It grows in moistened deciduous woods, shrubs, and disturbed areas with untamed soils.

Pharmacopoeial status: The plant is an official drug in both the Indian Pharmacopoeia and the British Pharmacopoeia. Despite being found to exhibit many biological activities, such as antitumor, anti-inflammatory, antioxidant, antimicrobial, hepatoprotective, nephroprotective, and otoprotective effects, and despite its past admittance in the British Pharmacopoeia, Hemidesmus lacks systematic scientific evaluation and its anticancer mechanisms remain elusive.

2. Common Forms and Preparations

While all parts of the plant have been used as crude drugs, the root extract is particularly valued for its extensive medicinal and biological properties. H. indicus is used in different forms such as powder, paste, leaves, churna (fine powder), juice, kwath (decoction), and syrup. Several formulations of H. indicus are commercially available to the public as herbal powder and topical creams/oils.

The decoction of the plant roots represents the most commonly used form in traditional medicine, and this preparation has also been used as the basis for scientific investigation of its anticancer properties, including cytotoxic, cytostatic, and cytodifferentiative potential on leukemia cell lines.

In the Indian food tradition, the plant is used to make beverages like nannari sharbat, and in the southern states of India (particularly Tamil Nadu), the pickled roots are served along with rice dishes.

Classical Ayurvedic polyherbal formulations incorporating H. indicus include: Sarivadyasavam (used in gout and skin diseases), Mathala Rasayanam (used in cough, cold, asthma, and bleeding disorders), Mahamanjistadi Kashayam (used in skin diseases, gout, syphilis, and non-healing wounds), Maha Vishagarbha Taila (used in sciatica, joint stiffness, and tinnitus), and Manasamitra Vatakam (used in speech problems, depression, and psychiatric disorders).

3. Traditional and Historical Use

3.1 Ayurveda

Hemidesmus indicus has been revered for its medicinal properties for nearly a thousand years in Indian traditional medicine, Ayurveda, and is commonly known as Indian Sarsaparilla, Anantamool, or Sariva. It is used as a vital herb for healing many ailments and is considered a magical spiritual dream herb in Ayurvedic medication. Classical Ayurvedic references to the plant appear in texts including the Charaka Samhita. It has long been known in traditional systems of medicine such as Ayurveda, Siddha, and Unani for its potent therapeutic properties.

It has long been used in Indian folk medicine to treat diversified diseases such as liver diseases, asthma, arthritis, bronchitis, syphilis, epileptic seizures, high blood pressure, skin diseases (eczema and psoriasis), rheumatism, chronic nervous diseases, impotence, and immune disorders. Mainly the roots of this plant are endowed with many pharmacological properties and have since long enjoyed a reputation as a tonic, alterative, diaphoretic, diuretic, and depurative.

In Ayurveda specifically, the plant is used in the treatment of bone-loss, low body weight, fever, stress, topical wounds, and psoriasis. Ayurvedic literature also depicts its use as anti-atherogenic, anti-spasmodic, memory-enhancing, immunopotentiating, and anti-inflammatory agents.

In the root's classical characterization, H. indicus root is described as sweet, cooling, and demulcent. It is used as a tonic, diuretic, and aphrodisiac. The whole root and root-bark are considered useful in syphilis, leucoderma, hemicrania, rheumatism, and in several liver and kidney disorders. Powdered root mixed with cow's milk is used to treat scanty and highly coloured urine and is a popular folk medicine preparation.

3.2 Siddha and Unani Systems

Hemidesmus indicus, commonly known as Indian Sarsaparilla or Anantamul, is a perennial shrub utilized in Ayurveda, Siddha, and Unani medicine to treat various diseases, including epileptic seizures and chronic nervous conditions. It has been used in Siddha, Ayurvedic, and Unani medicinal systems to treat inflammation, blood disorders, and other ailments. In Unani medicine, the roots have been used under the name "Ushba Hindi" (Ushbahindi) for syphilis and chronic rheumatic conditions.

3.3 Scope of Traditional Indications

Across the Indian subcontinent, the plant has traditionally been used for treating snakebites, scorpion stings, diabetes, urinary diseases, dyspnea, menorrhagia, oligospermia, anorexia, fever, abdominal colic and pain, dysentery, diarrhea, cough, rheumatism, headache, inflammation, pyrosis, skin diseases, leprosy, sexually transmitted diseases, and cancer.

In one traditional ethnobotanical preparation, the roots of H. indicus along with the roots of Tinospora cordifolia, Gmelina asiatica, and Celastrus paniculatus are crushed with asafetida and black cumin. The paste is then slightly warmed in an earthen pot and made into small pills that resemble jowar seeds. Four to five pills are recommended once daily for fifteen days in the treatment of whooping cough.

A paste of root powder applied topically is used to treat swellings, inflammation, and chronic rheumatism.

4. Key Constituents and Active Compounds

4.1 Characteristic Volatile Phenolic Compounds

The major component of the essential oil of the roots is the fragrant phenolic compound 2-hydroxy-4-methoxybenzaldehyde (2H4MB), a positional isomer of vanillin. This compound, also called MBALD, is found in the root extracts and is responsible for the plant's characteristic fragrance. Chemical constituents of polar extracts from H. indicus roots include triterpenic and steroidal saponins, tannins, coumarino-lignans, alkaloids, coumarins, and phenols, while the volatile fraction contains 2-hydroxy-4-methoxybenzaldehyde and (−) ledol as major compounds, along with over forty minor constituents.

4.2 Triterpenes and Sterols

The roots of H. indicus contain hexatriacontane, lupeol, its octacosanoate, α-amyrin, β-amyrin, its acetate, and sitosterol. The roots also contain the new coumarino-lignoid hemidesminine, hemidesmin I and hemidesmin II, and six pentacyclic triterpenes including two oleanenes and three ursenes.

Phytochemical investigations have reported the presence of 2-hydroxy-4-methoxybenzaldehyde, 4-hydroxy-3-methoxybenzaldehyde, hexa-tricostate acid, lupeol acetate, β-amyrin acetate, lupeol-1-octacosanol, flavonoids, steroids, saponins, terpenoids, lignins, phenolic compounds, tannins, cardiac glycosides, insulins, carbohydrates, and proteins from the roots.

4.3 Coumarino-Lignoids (Hemidesmins)

The plant is a good source of different bioactive chemical compounds including Hemidesmin-1 and Hemidesmin-2, α-amyrin, β-amyrin, lupeol acetate, β-sitosterol, hemidesmol, and hemidesterol, which are responsible for many of the pharmacological activities. The hemidesmins represent unique coumarino-lignoid structures first isolated from this species.

4.4 Additional Identified Compounds

The plant contains phytochemicals including 2-hydroxy-4-methoxy-benzoic acid, β-sitosterol, α- and β-amyrins, nerolidol, caryophyllene, ferulic acid, isoquercitrin, caffeic acid, gallic acid, borneol, lupeol, tetracyclic triterpene alcohols, hemidesminin, hemidesmin-1 and -2, resin acids, fatty acids, tannins, glycosides, and a ketone.

Flavonoid glycosides in the flowers include hyperoside, isoquercitrin, and rutin, whereas in the leaves only hyperoside and related compounds are present. Essential oil and triterpenoids are present in the roots.

5. Established and Proposed Mechanisms of Action

5.1 Anti-inflammatory Mechanisms

Studies have investigated anti-inflammatory effects through the examination of hepatic nuclear factor-kappa B (NF-κB), IκB kinase (IKK α/β) proteins, and TNFα and IL-6 expression in mouse models bearing hepatocarcinogenic changes. Acute phase inflammatory response was evaluated by carrageenan-induced rat paw edema formation. Anti-inflammatory mechanisms were also assessed by determining effects on membrane stabilization, nitric oxide (NO) inhibitory activity, and inhibition of leukocyte migration.

5.2 Anticancer and Pro-apoptotic Mechanisms

Proteasome inhibition represents an important anticancer strategy. Research has studied the mechanisms underlying the pro-apoptotic activity of a standardized decoction of H. indicus and explored its inhibition of proteasome activity in human leukemia cells. A potent antileukemic effect for H. indicus was observed, attributable to the modulation of different critical targets at protein and mRNA levels and the reduction of the 26S proteasome expression. Phytomarkers of H. indicus decoction were also found to pass through the enterocyte monolayer, indicating possible intestinal absorption.

In leukemia cell studies, H. indicus treatment markedly induced Bax and Bcl-2 protein expression and their ratio, suggesting that Bax was up-regulated and played an important role in the induction of apoptosis. H. indicus treatment also reduced the mRNA expression of Bcl-2 and Bax. Since an ubiquitin-proteasome-dependent pathway degrades both proteins, the ability of H. indicus to inhibit this pathway was a key finding.

5.3 Antivenom (PLA₂ Inhibition)

Hemidesmus indicus is utilized to inhibit phospholipase A2 (PLA2) activity, owing to the presence of lupeol acetate in its roots. Lupeol acetate could significantly neutralize lethality, haemorrhage, defibrinogenation, edema, and PLA2 activity induced by Daboia russellii venom. It also neutralized Naja kaouthia venom-induced lethality, cardiotoxicity, neurotoxicity, and respiratory changes in experimental animals.

5.4 Tyrosinase Inhibition

Root extracts of H. indicus contain the fragrant phenolic compound 2-hydroxy-4-methoxybenzaldehyde (MBALD) that has shown inhibitory potential against the biphenolase activity of tyrosinase. MBALD was shown to be more potent than vanillin in inhibiting monophenolase activity. Inhibition kinetic analysis confirmed this observation, with a higher Km value (0.395 mM) of monophenolase reaction in the presence of MBALD.

5.5 Hepatoprotective Mechanism

In ethanol-fed rat models, treatment resulted in significantly elevated liver marker enzyme activities, lipid peroxidation levels, and reduced antioxidant levels compared to controls. Oral administration of H. indicus extract for 30 days resulted in decreased thiobarbituric acid reactive substances (TBARS) levels, near-normal levels of glutathione-dependent enzymes, increased total protein, albumin, globulin and liver glycogen contents, and decreased liver marker enzyme activities.

6. Scientific Evidence by Area of Use

Important caveat: H. indicus has not been fully assessed on the basis of its safety and efficacy in humans. Although the crude extracts exhibit an array of pharmacological activities, more active phyto-constituents need to be identified by bioactivity-guided isolation, and more designed investigations are needed to comprehend multi-target network pharmacology, clarify the molecular mode of action, and ascertain efficacious doses. The following sections reflect the current state of evidence, which is predominantly preclinical.

6.1 Anticancer Activity

In vitro and animal evidence (preliminary): Researchers tested the anticancer activity of the decoction of the plant roots by investigating its cytotoxic, cytostatic, and cytodifferentiative potential on HL-60, a human promyelocytic leukemic cell line that can be stimulated to terminally differentiate toward granulocytes and/or macrophages. The cytodifferentiating, cytotoxic, and cytostatic activities of Hemidesmus indicus were found to offer a scientific basis for its use in traditional medicine, and its potent antileukemic activity provides pre-clinical evidence for its traditional use in anticancer pharmacology. Further experiments were identified as needed to determine the in vivo anticancer potential of the plant decoction and its components.

Research published in Scientific Reports (2019) further studied the anticancer strategy of proteasome inhibition by H. indicus, building on earlier work demonstrating mitochondrial pathway-mediated antileukemic effects. H. indicus showed an anti-leukemic effect on leukemia cells; the phytochemicals inhibit the proteasome expression, leading to apoptosis.

One study performed virtual screening of 19 protein receptors having a major role in the signal transduction pathway of breast cancer development against 47 compounds present in H. indicus. This remains computational evidence only, with no clinical data in humans.

Strength of evidence: All anticancer evidence to date is in vitro (cell lines) or computational. No human clinical trials have been published. Evidence is preliminary and cannot be translated to clinical recommendations.

6.2 Anti-inflammatory and Anti-arthritic Activity

In vivo (animal) evidence: A significant inhibition of paw edema formation was observed in healthy rats as well as in rats bearing early hepatocarcinogenic changes with oral administration of a polyherbal decoction containing H. indicus. Anti-inflammatory activity was also demonstrated at a dose level of 100 mg/kg in combined preparations. Methanolic crude extracts and methanolic extracts from H. indicus root showed reduced inflammation activity induced by Salmonella typhimurium, in which extracts exhibited inhibition of type three secretory proteins encoded by SPI-1 (involved in invasion and enteritis) and SPI-2 (involved in intracellular survival).

Strength of evidence: Anti-inflammatory data is primarily from animal models (carrageenan paw edema, rodent arthritis models) and in vitro assays. No randomized controlled trials in humans are available.

6.3 Hepatoprotective Activity

Animal evidence: H. indicus is an indigenous Ayurvedic medicinal plant used in soft drinks in India. One study examined the effects of its ethanolic root extract on experimental liver damage in rats, evaluating hepatoprotective effects against hepatotoxicity induced by ethanol at a dosage of 5 g/kg body weight for 60 days. The H. indicus root extract was given at a dose of 500 mg/kg body weight for the last 30 days of the experiment.

In vivo investigations in rats confirmed that a polyherbal decoction containing H. indicus can significantly protect rat livers against carcinogenic changes mediated by diethylnitrosamine (DEN) without producing any toxic side effects. The decoction was also reported to induce significant cytotoxicity against human hepatoma HepG2 cells in vitro.

Strength of evidence: Hepatoprotective evidence is limited to animal models and cell-line studies. There are no published human clinical trials specifically evaluating H. indicus for liver protection.

6.4 Antidiabetic Activity

The major pharmacological properties of H. indicus have been characterized in the literature to include antioxidant, anti-diabetic, anti-cancer, anti-ulcerogenic, anti-inflammatory, anti-microbial, hepatoprotection, neuroprotection, cardioprotection, and nephroprotection. Antidiabetic properties have been evaluated using ethanol root extracts in preclinical models, with investigators examining blood glucose modulation.

Strength of evidence: Antidiabetic activity evidence is derived from in vitro and animal studies only. No human clinical trials have been published evaluating H. indicus specifically for diabetes or blood glucose regulation.

6.5 Antimicrobial Activity

The anticancer, antioxidant, anti-inflammatory, antipyretic, analgesic, antimicrobial, antidiabetic, hepatoprotective, cardioprotective, renoprotective, neuroprotective, and immunomodulatory properties of H. indicus have been investigated in numerous in vivo and in vitro studies. Among these, the antioxidant and antimicrobial activity was well documented.

Several effects have been demonstrated in studies, including antidiarrhoeal, antiasthmatic, hepatoprotective, antiulcerogenic, antimicrobial, and antihelminthic activities.

Strength of evidence: Antimicrobial data is derived predominantly from in vitro disk-diffusion and broth dilution assays against bacterial and fungal strains. No clinical trials have been conducted.

6.6 Antivenom Activity

A published study reports the isolation and purification of lupeol acetate from the methanolic root extract of H. indicus which could neutralize venom-induced action of Daboia russellii (Russell's viper) and Naja kaouthia (monocled cobra) on experimental animals. Lupeol acetate significantly neutralized lethality, haemorrhage, defibrinogenation, edema, and PLA2 activity induced by Daboia russellii venom. Lupeol acetate also potentiated the protection by snake venom antiserum action against Daboia russellii venom-induced lethality in male albino mice. Venom-induced changes in lipid peroxidation and superoxide dismutase activity were antagonized by lupeol acetate.

H. indicus root extracts effectively inhibited viper venom-induced lethal coagulation, hemorrhagic, and inflammatory activities in experimental studies.

Strength of evidence: All antivenom evidence is preclinical (in vivo rodent models). These studies are mechanistically informative but cannot be translated to human clinical use without further investigation.

6.7 Skin Diseases (including Psoriasis)

One open-label clinical study examined patients with mild-to-moderate psoriasis who received Hemidesmus indicus orally. The result showed a decrease in scaling, itching, and Psoriasis Area Severity Index (PASI) scores. The conclusion noted that although the formulation exhibited improvement, it was impossible to separate the precise function of Hemidesmus indicus due to the usage of several herbs in the formulation.

In a separate pilot study, 50 cc of H. indicus root decoction taken twice a day for six weeks was evaluated. Pruritus and lesion healing improved; two patients experienced slight stomach pain. This study lacks a large sample size and a control group, but suggests potential efficacy in chronic skin conditions.

Strength of evidence: Limited to small, open-label, or uncontrolled clinical observations. These studies cannot establish causality, particularly in polyherbal formulations. Well-controlled human trials are needed.

6.8 Renoprotective (Kidney Protective) Activity

The renoprotective effect of H. indicus, a herbal drug used in gentamicin-induced renal toxicity, has been investigated. Studies aimed to prove the safety and efficacy of H. indicus in the management of nephrotoxicity induced by aminoglycosides such as gentamicin.

Strength of evidence: Renoprotective effects have been studied in animal models of drug-induced nephrotoxicity. No human clinical evidence is available.

6.9 Antioxidant Activity

Over the past decades, several reports have highlighted the potential pharmacological properties with numerous lines of evidence from in vitro and in vivo studies. Main pharmacological activities include antioxidant, anti-inflammatory, anti-arthritic, anti-cancerous, anti-diabetes, anti-cataractous, anti-diarrhoeal, anti-HIV-1, monophenolase activity, antivenom, antihepatocarcinogenic, anti-angiogenic, and acetylcholinesterase and butyrylcholinesterase inhibitory activity.

Strength of evidence: Antioxidant activity has been consistently demonstrated in in vitro assays (DPPH, ABTS radical scavenging). Human clinical validation has not been reported.

7. Body Systems and Health Areas of Association

Dermatological system: Skin diseases, blood disorders, fever, respiratory conditions, gastrointestinal disturbances, and urinary tract infections are among the ailments for which the plant is extensively used in treatment. Psoriasis, eczema, leprosy, and leucoderma are noted specific indications in traditional systems.
Hepatic system: H. indicus root is an ingredient in Ayurvedic preparations against blood diseases and inflammation. Hepatoprotective activity has been demonstrated in animal models of chemical-induced liver damage.
Immune and hematological system: Anti-HIV-1 activity and immunomodulatory properties have been reported from in vitro and in vivo studies.
Musculoskeletal system: Rheumatism, arthritis, and bone-loss are traditional indications supported by preclinical anti-inflammatory evidence.
Renal and urinary system: Diuretic and renoprotective properties are noted in both traditional medicine and preclinical research.
Nervous system: Different pharmacological experiments have demonstrated antiepileptic, anticonvulsant, antipsychotic, and nootropic activities in in vitro and in vivo models.
Cardiovascular system: Cardioprotective properties, including effects on ischemia-reperfusion injury in isolated rat hearts, have been studied.
Endocrine/metabolic system: Anti-diabetic and anti-hyperlipidemic activities have been studied preclinically.
Toxicological/envenomation: Traditional use as an antidote for snakebites, supported by preclinical studies on venom neutralization by lupeol acetate.

8. Dosage Forms and Dosages Reported in Studies

One hepatoprotective study examined the ethanolic root extract administered to rats against ethanol-induced hepatotoxicity at a dosage of 5 g/kg body weight ethanol for 60 days, with the H. indicus root extract given at a dose of 500 mg/kg body weight for the last 30 days. This is an animal study dose and cannot be directly extrapolated to humans.

In an open-label clinical study on psoriasis, the intervention involved 3 g of powdered Hemidesmus indicus root twice a day for 4 weeks.

In a separate pilot study on skin conditions, the intervention consisted of 50 cc of Hemidesmus indicus root decoction taken twice a day for six weeks.

Quality control methods using HPTLC phytochemical fingerprinting and proximate analysis of H. indicus root powder were developed. In acute toxicity studies using albino Swiss mice, the drug was found to be relatively safe up to 7 g/kg bodyweight dose. This is an animal LD50 estimation and does not define a safe human dose.

More designed investigations are needed to comprehend the multi-target network pharmacology, clarify the molecular mode of action, and ascertain the efficacious doses of H. indicus. No standardized human dosage has been established through controlled clinical trials.

9. Safety Considerations and Interactions

9.1 Overall Safety Profile

Clinical trials and conventional use have not revealed any significant side effects. High dosages may cause mild gastrointestinal problems (diarrhea, bloating). When taken within the suggested dosage range, it is regarded as safe.

The phytochemistry and pharmacology of H. indicus have been extensively investigated, but studies on toxicology of the extracts of the plant parts in different solvents are very few. H. indicus has not been fully assessed on the basis of its safety and efficacy in humans.

9.2 Acute Toxicity (Preclinical)

Toxicity studies of crude aqueous ethanolic extract of the roots of Hemidesmus indicus var. pubescens were carried out in two growth phases. The drug was administered orally and intraperitoneally, and was found to possess nonspecific changes in liver. This finding, from a preclinical study, indicates that high doses of root extracts may warrant monitoring of hepatic parameters.

9.3 Gastrointestinal Effects

In a pilot clinical study, when patients received 50 cc of H. indicus root decoction twice a day for six weeks, two patients experienced slight stomach pain as an adverse event.

9.4 Drug Interactions

Given that preclinical studies have demonstrated hypoglycemic, antihypertensive, and antithrombotic activities, there is a theoretical basis for interactions with antidiabetic agents, antihypertensives, and anticoagulants, respectively. There is limited information on specific drug interactions with Hemidesmus indicus. These potential interactions have not been formally evaluated in human pharmacokinetic or pharmacodynamic studies.

9.5 Adulteration and Quality Control Concerns

Hemidesmus indicus and its substitute Decalepis hamiltonii are important and widely used medicinal plants belonging to the family Apocynaceae; both majorly contain phyto-constituents such as hexatriacontane, lupeol, α-amyrin, β-amyrin, 2-hydroxy-4-methoxybenzaldehyde (2H4MB), and sitosterol. The chemical similarity between these two species has led to documented substitution and adulteration in commercial markets, which presents a quality control challenge for consumers and manufacturers.

9.6 Conservation Status

H. indicus is identified as one of the most traded medicinal plants. The increasing preference for herbal-based medicines has resulted in increasing harvesting of H. indicus from its natural habitat. Deforestation and overexploitation of the plant species lead to extinction, and sustainable utilization of medicinal plants is recommended.

10. Summary of Evidence Status

Modern phytochemical and pharmacological research support several of the plant's ethnomedicinal claims and highlight its potential as a source of novel therapeutic agents. However, the overall evidence base remains predominantly preclinical. The extensive uses of H. indicus as a folk remedy for various ailments have led to its introduction to the commercial market as a health supplement. Various pharmacological actions of the plant have been validated through preclinical studies, with demonstrated efficacy as an anti-inflammatory, anti-arthritic, antioxidant, hepatoprotective, antiulcer, antivenom, anti-hyperlipidemic, and antimicrobial agent.

Comprehensive reviews hope to compile and improve existing knowledge on the potential utilization of H. indicus in complementary and alternative medicine. The transition from robust traditional use and promising preclinical data to rigorously validated clinical therapies has not yet occurred for this plant, and well-designed, adequately powered randomized controlled trials in humans remain an unmet need across all its proposed indications.

References

Health Conditions

Health conditions that Hemidesmus may help support.

No conditions available.

Body Systems

Body systems that Hemidesmus may help support.

No body systems available.